75 related articles for article (PubMed ID: 10810198)
21. 1999 plenary session: Friday imaging symposium : evaluation of focal pulmonary abnormalities with FDG PET.
Patz EF
Radiographics; 2000; 20(4):1182-5. PubMed ID: 10903708
[No Abstract] [Full Text] [Related]
22. Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients.
Ohno Y; Koyama H; Yoshikawa T; Takenaka D; Seki S; Yui M; Yamagata H; Aoyagi K; Matsumoto S; Sugimura K
Radiology; 2015 Jun; 275(3):849-61. PubMed ID: 25584709
[TBL] [Abstract][Full Text] [Related]
23. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
[TBL] [Abstract][Full Text] [Related]
24. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma.
Ahuja V; Coleman RE; Herndon J; Patz EF
Cancer; 1998 Sep; 83(5):918-24. PubMed ID: 9731895
[TBL] [Abstract][Full Text] [Related]
25. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
Nestle U; Kremp S; Grosu AL
Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
[TBL] [Abstract][Full Text] [Related]
26. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
[TBL] [Abstract][Full Text] [Related]
27. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET.
Hara T; Inagaki K; Kosaka N; Morita T
J Nucl Med; 2000 Sep; 41(9):1507-13. PubMed ID: 10994730
[TBL] [Abstract][Full Text] [Related]
28. Radiation-induced esophagitis on FDG PET imaging.
Bhargava P; Reich P; Alavi A; Zhuang H
Clin Nucl Med; 2003 Oct; 28(10):849-50. PubMed ID: 14508282
[No Abstract] [Full Text] [Related]
29. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in bronchopulmonary and pleural cancers].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S23-41. PubMed ID: 12739334
[No Abstract] [Full Text] [Related]
30. [PET-imaging proves giant-cell arteritis as the cause of FUO in a patient with a pulmonary nodule of unknown malignancy].
Rupp J; Reincke B; Schaaf B; Dalhoff K
Pneumologie; 2003 Jul; 57(7):383-6. PubMed ID: 12861494
[TBL] [Abstract][Full Text] [Related]
31. [A case of radiologically negative small-cell lung carcinoma successfully detected early by whole-body FDG-PET].
Demura Y; Mizuno S; Wakabayashi M; Totani Y; Okamura S; Ameshima S; Ishizaki T; Miyamori I; Ito H; Yonekura Y
Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):45-9. PubMed ID: 11296386
[TBL] [Abstract][Full Text] [Related]
32. [Positron-emission tomography (PET) and non-small cell bronchial cancer].
Vaylet F
Rev Pneumol Clin; 2000 Oct; Suppl 2():21-4. PubMed ID: 11280863
[No Abstract] [Full Text] [Related]
33. [Positron emission tomography (PET): application in urogenital system oncologic diseases].
Lomeña F; Simó M; Setoain X; Pérez G
Arch Esp Urol; 2001; 54(6):649-60. PubMed ID: 11512406
[TBL] [Abstract][Full Text] [Related]
34. Lepidic spread of primary lung adenocarcinoma on FDG-PET.
Gradinscak DJ; Fulham MJ; Mohamed A; Constable CJ
Clin Nucl Med; 2004 Mar; 29(3):206-8. PubMed ID: 15162995
[No Abstract] [Full Text] [Related]
35. [How I investigate ... a broncho-pulmonary cancer by metabolic imaging (PET-18-FDG)].
Bury T; Duysinx B; Corhay JL; Bartsch P; Rigo P
Rev Med Liege; 2000 Mar; 55(3):178-83. PubMed ID: 10823009
[TBL] [Abstract][Full Text] [Related]
36. [The therapeutic impact of PET-FDG scanning in broncho-pulmonary cancer].
Blondet C; Vaylet F; Cochet A; Bonardel G; Mognetti T; Maszelin P; Gaillard JF; Foehrenbach H
Rev Mal Respir; 2005 Feb; 22(1 Pt 1):35-43. PubMed ID: 15968756
[TBL] [Abstract][Full Text] [Related]
37. Metabolic imaging of a solitary pulmonary nodule.
Siraj QH; Masoomi MA; Griffiths P
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):578. PubMed ID: 11914899
[No Abstract] [Full Text] [Related]
38. [Positron emission tomography in thoracic radiography].
Vaylet F; Foehrenbach H; Guigay J; de Dreuille O; Maszelin P; Grassin F; Margery J; Dot JM; Gaillard JF; L'Her P
Cancer Radiother; 2000 Nov; 4 Suppl 1():13s-16s. PubMed ID: 11194952
[TBL] [Abstract][Full Text] [Related]
39. Endobronchial epithelial-myoepithelial carcinoma of the lung.
Kim CH; Jeong JS; Kim SR; Lee YC
Thorax; 2018 Jun; 73(6):593-594. PubMed ID: 29196470
[No Abstract] [Full Text] [Related]
40. Non-small cell lung cancer: staging at whole-body PET.
Podoloff DA
Radiology; 2000 Dec; 217(3):918-9. PubMed ID: 11110966
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
